Jennifer K. Pai, ScD, Merck & Co., Inc.

Jennifer K. Pai, ScD Jennifer K. Pai, ScD is currently the Director of Data Sciences, Strategy, and Platforms at Merck & Co., Inc focused on advancing translational applications of data sciences and predictive analytics to accelerate the development of observational and real world evidence research. Previous to this role, Dr. Pai held leadership roles in the IT organization as the health informatics and data strategy lead focused broadly on enabling data interoperability, increased data utility, and analytics across the drug discovery pipeline.   Prior to joining Merck, Dr. Pai was on the faculty at Harvard Medical School where she led an independent research program evaluating novel plasma and genetic biomarkers as risk predictors of cardiovascular disease. Dr. Pai has coauthored >45 publications in leading journals and served as expert reviewer for journals, scientific conferences, and national funding agencies. She holds degrees from The Johns Hopkins University and a Doctorate degree in Epidemiology from Harvard University.


12:00 PM - 12:40 PM

Open Discussion: New Collaborative Models to Impact Patients in More Meaningful Ways

Several industry pioneers will lead an audience-wide discussion on the collaborative models in use that are impacting patients now. This is your unique opportunity to gain an understanding of how industry peers are innovating via collaborative models with each other, technology partners and academia. This is also a great opportunity to expand your network and possibly find your next partner.



  • M. Khair ElZarrad Ph.D., MPH

    M. Khair ElZarrad Ph.D., MPH Deputy Director, Office of Medical Policy Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA)

Download Latest Agenda